{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:51Z","timestamp":1790873811725,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.14283\/jpad.2023.91","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T05:54:27Z","timestamp":1688709267000},"page":"171-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Global Energy Metabolism Deficit in Alzheimer Disease Brain"],"prefix":"10.1016","volume":"11","author":[{"given":"Viharkumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.C.","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Salamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Raife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.14283\/jpad.2023.91_bib1","first-page":"545","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimer's & Dementia"},{"issue":"6","key":"10.14283\/jpad.2023.91_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.14283\/jpad.2023.91_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"issue":"6311","key":"10.14283\/jpad.2023.91_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"issue":"8","key":"10.14283\/jpad.2023.91_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nature medicine"},{"issue":"11","key":"10.14283\/jpad.2023.91_bib6","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.38.11.1682","article-title":"Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease","volume":"38","author":"Crystal","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2023.91_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"issue":"4","key":"10.14283\/jpad.2023.91_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2023.91_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2012.11.014","article-title":"Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?","volume":"85","author":"Mullane","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"10.14283\/jpad.2023.91_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.NT.0000767180.04997.ec","article-title":"Dementia Experts on Why the FDA Approval of Aducanumab for Alzheimer's Gets Mixed Grades","volume":"21","author":"Talan","year":"2021","journal-title":"Neurology Today"},{"issue":"5","key":"10.14283\/jpad.2023.91_bib11","first-page":"363","article-title":"Lecanemab Gains FDA Approval for Early Alzheimer Disease","volume":"329","author":"Larkin","year":"2023","journal-title":"JAMA"},{"issue":"7113","key":"10.14283\/jpad.2023.91_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.14283\/jpad.2023.91_bib13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3233\/JAD-160326","article-title":"FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging","volume":"53","author":"Krell-Roesch","year":"2016","journal-title":"Journal of Alzheimers Disease"},{"key":"10.14283\/jpad.2023.91_bib14","article-title":"Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease","author":"Mill","year":"2021","journal-title":"Journal of Pharmaceutical Analysis"},{"issue":"1","key":"10.14283\/jpad.2023.91_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","article-title":"\u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer's disease pathology","volume":"17","author":"Shippy","year":"2020","journal-title":"Journal of Neuroinflammation"},{"key":"10.14283\/jpad.2023.91_bib16","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M116.062349","article-title":"Multi-omics evidence for inheritance of energy pathways in red blood cells","author":"Weisenhorn","year":"2016","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.14283\/jpad.2023.91_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.44.1.127","article-title":"The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man","volume":"44","author":"Reivich","year":"1979","journal-title":"Circ Res"},{"issue":"11","key":"10.14283\/jpad.2023.91_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","volume":"19","author":"Ch\u00e9telat","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"5","key":"10.14283\/jpad.2023.91_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease","volume":"35","author":"Simpson","year":"1994","journal-title":"Ann Neurol"},{"issue":"1","key":"10.14283\/jpad.2023.91_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005072-199501000-00005","article-title":"Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone","volume":"54","author":"Harr","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.14283\/jpad.2023.91_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.14283\/jpad.2023.91_bib22","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1194\/jlr.R046599","article-title":"Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester","volume":"55","author":"Hashim","year":"2014","journal-title":"J Lipid Res"},{"key":"10.14283\/jpad.2023.91_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2350-12-137","article-title":"Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, doubleblind, placebo-controlled study","volume":"12","author":"Henderson","year":"2011","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.14283\/jpad.2023.91_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.13107","article-title":"Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, beta-amyloid toxicity, and astrocyte function","volume":"134","author":"Hertz","year":"2015","journal-title":"J Neurochem"},{"key":"10.14283\/jpad.2023.91_bib25","doi-asserted-by":"crossref","first-page":"807970","DOI":"10.3389\/fnut.2021.807970","article-title":"Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review","volume":"8","author":"Lilamand","year":"2021","journal-title":"Front Nutr"},{"issue":"4","key":"10.14283\/jpad.2023.91_bib26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MCO.0000000000000759","article-title":"Ketogenic diet therapy in Alzheimer's disease: an updated review","volume":"24","author":"Lilamand","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.14283\/jpad.2023.91_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-020-00615-4","article-title":"Are ketogenic diets promising for Alzheimer's disease? A translational review","volume":"12","author":"Lilamand","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2023.91_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer's disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.14283\/jpad.2023.91_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/msb.20145228","article-title":"Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible A rchean ocean","volume":"10","author":"Keller","year":"2014","journal-title":"Molecular systems biology"},{"issue":"3","key":"10.14283\/jpad.2023.91_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/genetics\/94.3.719","article-title":"Genetic control of glycolysis in human erythrocytes","volume":"94","author":"Gilroy","year":"1980","journal-title":"Genetics"},{"issue":"8","key":"10.14283\/jpad.2023.91_bib31","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/trf.12605","article-title":"The heritability of metabolite concentrations in stored human red blood cells","volume":"54","author":"van't Erve","year":"2014","journal-title":"Transfusion"},{"key":"10.14283\/jpad.2023.91_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.freeradbiomed.2014.07.040","article-title":"Heritability of glutathione and related metabolites in stored red blood cells","volume":"76","author":"van' t Erve","year":"2014","journal-title":"Free Radical Biology and Medicine"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:09:13Z","timestamp":1737338953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2274580724001213"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.91","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Energy Metabolism Deficit in Alzheimer Disease Brain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.91","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}